Department of Pulmonology, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), 4434-502 Vila Nova de Gaia, Portugal.
UMIB-Unit for Multidisciplinary Research in Biomedicine, ITR-Laboratory for Integrative and Translational Research in Population Health, University of Porto, 4050-313 Porto, Portugal.
Genes (Basel). 2023 Feb 21;14(3):541. doi: 10.3390/genes14030541.
Primary ciliary dyskinesia (PCD) is a rare hereditary condition characterized by decreased mucociliary clearance of the airways and a compromised reproductive system, resulting in male and female infertility. Several mutations with varied clinical and pathological features have been documented, making diagnosis a challenging process. The purpose of this study is to describe the clinical and pathological features of Portuguese patients with PCD and to examine their genetic variants. A retrospective observational analysis was conducted with patients who were being monitored at a bronchiectasis outpatient clinic in 2022 and had a confirmed or high-likelihood diagnosis of PCD. In total, 17 patients were included in the study, with 12 (66.7%) having PCD confirmed and 5 (29.4%) having a high-likelihood diagnosis. Furthermore, 12 patients were subjected to transmission electron microscopy (TEM), with 7 (58.3%) exhibiting one hallmark defect. Genetic test data was obtained for all 17 patients, with 7 of them (41.2%) displaying a pathogenic/likely pathogenic mutation in homozygosity. To summarize, PCD is an uncommon but significant hereditary illness with consequences regarding morbidity and mortality. Despite the lack of a specific treatment, it is critical to confirm the diagnosis with genetic testing in order to effectively manage the disease and its accompanying disorders.
原发性纤毛运动障碍(PCD)是一种罕见的遗传性疾病,其特征为气道黏液纤毛清除功能降低和生殖系统受损,导致男性和女性不孕。已经记录了几种具有不同临床和病理特征的突变,这使得诊断成为一个具有挑战性的过程。本研究旨在描述葡萄牙 PCD 患者的临床和病理特征,并研究其遗传变异。对 2022 年在支气管扩张门诊接受监测且被确诊或高度疑似 PCD 的患者进行了回顾性观察性分析。共有 17 名患者纳入研究,其中 12 名(66.7%)被确诊为 PCD,5 名(29.4%)被高度疑似诊断。此外,对 12 名患者进行了透射电子显微镜检查(TEM),其中 7 名(58.3%)存在一个标志性缺陷。对所有 17 名患者进行了基因检测数据,其中 7 名(41.2%)存在纯合子致病性/可能致病性突变。总之,PCD 是一种罕见但严重的遗传性疾病,会导致发病率和死亡率的增加。尽管没有特定的治疗方法,但通过基因检测来确认诊断对于有效管理疾病及其伴随的疾病至关重要。